Literature DB >> 28416045

Hypnotics and the Risks of Dementia.

Walter James1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28416045      PMCID： PMC5443746          DOI： 10.5664/jcsm.6632

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  10 in total

1.  Why are benzodiazepines not yet controlled substances?

Authors:  Nicholas Moore; Antoine Pariente; Bernard Bégaud
Journal:  JAMA Psychiatry       Date:  2015-02       Impact factor: 21.596

2.  I petitioned the FDA to restrict hypnotics: here is why.

Authors:  Daniel F Kripke
Journal:  Sleep Med       Date:  2015-12-31       Impact factor: 3.492

3.  Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS).

Authors:  John Gallacher; Peter Elwood; Janet Pickering; Antony Bayer; Mark Fish; Yoav Ben-Shlomo
Journal:  J Epidemiol Community Health       Date:  2011-10-27       Impact factor: 3.710

4.  Benzodiazepine use and risk of dementia: a nested case-control study.

Authors:  Rajaa Lagnaoui; Bernard Bégaud; Nicholas Moore; Anicet Chaslerie; Annie Fourrier; Luc Letenneur; Jean François Dartigues; Yola Moride
Journal:  J Clin Epidemiol       Date:  2002-03       Impact factor: 6.437

5.  Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.

Authors:  Michael J Sateia; Daniel J Buysse; Andrew D Krystal; David N Neubauer; Jonathan L Heald
Journal:  J Clin Sleep Med       Date:  2017-02-15       Impact factor: 4.062

6.  Effect of benzodiazepine discontinuation on dementia risk.

Authors:  Chi-Shin Wu; Te-Tien Ting; Sheng-Chang Wang; I-Shou Chang; Keh-Ming Lin
Journal:  Am J Geriatr Psychiatry       Date:  2011-02       Impact factor: 4.105

7.  The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data.

Authors:  Chi-Shin Wu; Sheng-Chang Wang; I-Shou Chang; Keh-Ming Lin
Journal:  Am J Geriatr Psychiatry       Date:  2009-07       Impact factor: 4.105

8.  Risk of dementia in patients with insomnia and long-term use of hypnotics: a population-based retrospective cohort study.

Authors:  Pin-Liang Chen; Wei-Ju Lee; Wei-Zen Sun; Yen-Jen Oyang; Jong-Ling Fuh
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

9.  Benzodiazepine use and risk of dementia: prospective population based study.

Authors:  Sophie Billioti de Gage; Bernard Bégaud; Fabienne Bazin; Hélène Verdoux; Jean-François Dartigues; Karine Pérès; Tobias Kurth; Antoine Pariente
Journal:  BMJ       Date:  2012-09-27

10.  Benzodiazepine use and risk of Alzheimer's disease: case-control study.

Authors:  Sophie Billioti de Gage; Yola Moride; Thierry Ducruet; Tobias Kurth; Hélène Verdoux; Marie Tournier; Antoine Pariente; Bernard Bégaud
Journal:  BMJ       Date:  2014-09-09
  10 in total
  2 in total

1.  Adverse Effects of Hypnotic Medications.

Authors:  Michael J Sateia; Daniel J Buysse; Andrew D Krystal; David N Neubauer
Journal:  J Clin Sleep Med       Date:  2017-06-15       Impact factor: 4.062

2.  Current Clinical Practice for the Use of Hypnotics to Manage Primary Insomnia in Adults in a Tertiary Hospital in Saudi Arabia: An Audit Study.

Authors:  Ali Dobia; Kath Ryan; Daniel Grant; Ahmed BaHammam
Journal:  Pharmacy (Basel)       Date:  2019-01-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.